Cyclerion Therapeutics In... (CYCN)
NASDAQ: CYCN
· Real-Time Price · USD
2.39
0.06 (2.58%)
At close: Aug 15, 2025, 3:59 PM
2.39
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
Cyclerion Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.17M | 2.08M | 2M | 194K | n/a | n/a | n/a | 1.63M | 1.63M | 1.7M | 1.92M | 479K | 556K | 3.48M | 3.32M | 3.27M | 3.6M | 1.34M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17K | 65K | 113K | 113K | 96K | 48K | n/a | n/a | n/a |
Gross Profit | 2.08M | 2.08M | 2M | 194K | n/a | n/a | n/a | 1.63M | 1.63M | 1.68M | 1.86M | 366K | 443K | 3.39M | 3.27M | 3.27M | 3.6M | 1.34M |
Operating Income | -3.75M | -3.47M | -3.63M | -5.92M | -10.81M | -13.67M | -19.09M | -24.65M | -29.24M | -38.43M | -44.37M | -51.36M | -52.04M | -54.78M | -55.19M | -60.08M | -70.58M | -74.07M |
Interest Income | 129K | 160K | 208K | 281K | 346K | 346K | 358K | 257K | 261K | 244K | 156K | 156K | 45K | n/a | n/a | n/a | 93K | 231K |
Pretax Income | -1.95M | -2.94M | -3.06M | -5.28M | -10.47M | -13.32M | -18.74M | -24.26M | -28.85M | -38.05M | -44.08M | -47.64M | -48.43M | -51.23M | -51.65M | -60.1M | -67.62M | -70.97M |
Net Income | -1.95M | -2.94M | -3.06M | -5.28M | 3.01M | 149K | -5.09M | -10.43M | -28.27M | -37.43M | -43.62M | -47.36M | -48.38M | -51.22M | -51.65M | -60.1M | -67.62M | -70.97M |
Selling & General & Admin | 5.7M | 5.27M | 5.34M | 5.87M | 6.75M | 8.83M | 10.53M | 12.26M | 13.66M | 13.82M | 14.5M | 15.41M | 16.49M | 19.21M | 20.62M | 23.47M | 26.9M | 27.29M |
Research & Development | 229K | 278K | 286K | 254K | 753K | 1.53M | 5.26M | 9.69M | 16.19M | 25.52M | 31.49M | 37.5M | 37.45M | 39.29M | 37.64M | 39.27M | 45.94M | 47.68M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -608K | -608K | -842K | -1.33M | -720K | -720K | -486K | n/a | n/a | n/a | n/a |
Operating Expenses | 5.93M | 5.55M | 5.63M | 6.12M | 7.51M | 10.37M | 15.79M | 21.34M | 29.24M | 38.5M | 44.67M | 51.84M | 52.6M | 57.39M | 57.63M | 62.47M | 72.84M | 74.97M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 183K | 183K | 228K | 234K | 52K | 57K | 18K | 16K | 15K | 10K | 4K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.93M | 5.55M | 5.63M | 6.12M | 7.51M | 10.37M | 15.79M | 21.34M | 29.24M | 38.5M | 44.67M | 51.84M | 52.6M | 57.39M | 57.63M | 62.47M | 72.84M | 74.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -176K | -359K | -581K | -626K | -456K | -272K | -50K | 1K | 7K | 6K | 6K | n/a |
Shares Outstanding (Basic) | 3.07M | 2.56M | 2.55M | 2.53M | 2.51M | 2.49M | 2.47M | 2.44M | 2.28M | 2.18M | 2.18M | 2.07M | 2.07M | 2.07M | 2.06M | 2.16M | 1.79M | 1.7M |
Shares Outstanding (Diluted) | 3.07M | 2.56M | 2.55M | 2.53M | 2.51M | 2.49M | 2.47M | 2.44M | 2.28M | 2.18M | 2.18M | 2.07M | 2.07M | 2.07M | 2.06M | 2.16M | 1.79M | 1.7M |
EPS (Basic) | -0.75 | -1.17 | -1.23 | -2.12 | -5.19 | -6.49 | -8.98 | -11.53 | -13.14 | -17.77 | -20.94 | -22.94 | -23.19 | -25.79 | -27.37 | -34.45 | -40.95 | -45.95 |
EPS (Diluted) | -0.75 | -1.17 | -1.23 | -2.12 | -5.19 | -6.49 | -8.98 | -11.53 | -13.14 | -17.77 | -20.94 | -22.94 | -23.19 | -25.79 | -27.37 | -34.45 | -40.95 | -45.95 |
EBITDA | -3.75M | -3.47M | -3.55M | -5.75M | -7.33M | -10.19M | -15.69M | -21.47M | -29.36M | -38.55M | -44.44M | -47.7M | -48.33M | -50.07M | -50.28M | -58.31M | -68.86M | -72.74M |
EBIT | -2.41M | -3.47M | -3.63M | -5.92M | -7.51M | -10.3M | -15.64M | -21.19M | -28.98M | -38.23M | -44.26M | -48.57M | -49.36M | -51.22M | -51.63M | -59.2M | -69.25M | -73.63M |
Depreciation & Amortization | n/a | n/a | 43.28K | 87.09K | 6.7M | 6.82M | 6.82M | 6.38M | -198.25K | -303.33K | -296.92K | 140.08K | 713K | 796K | 1.01M | 1.43M | 1.42M | 1.93M |